Von Hippel Lindau Disease: Two Sisters and one Disease

Authors

Keywords:

Von Hippel Lindau disease, hemangioblastomas, pheochromocytoma

Abstract

Introduction: Von Hippel-Lindau disease is an autosomal dominantly inherited condition, which predisposes individuals to multiple malignancies. Germline pathogenic variants of the VHL gene induce individuals to specific types of benign, malignant and cyst-like tumors in many organ systems. Evaluation and treatment of these patients require a multidisciplinary approach. Penetrance is incomplete, but high in mutation carriers, so that almost all have developed characteristic tumors before the age of 60 years. The average life expectancy was less than 50 years before the current follow-up protocols, which should be started in childhood. Prognosis depends on early detection and treatment of these tumors.

Objective: To describe the evolution of the disease and the follow-up performed so far in the two sisters with similar diagnoses, but with different forms of evolution of the disease, despite being a genetic disease.

Case presentation: The case of two sisters with the same genetic disease is presented, with different cysts and tumors, as well as complications typical of their evolution, and classic images of these and their behavior are shown.

Conclusions: According to the proposed classifications for the disease, 80% are Type 1, with absence of pheochromocytoma, as in the cases of this research. The infrequent nature of the disease, the genetic characteristics and the variability of lesions in the same patient, benign and malignant, have an independent expression in each subject, as well as the response to established treatments.

Downloads

Download data is not yet available.

Author Biographies

Fidel Concepción Quero, Hospital Hermanos Ameijeiras

Especialista en Medicina Interna Master en investigacion profesor asistente

Inés Noa Hechavarría, Hospital Hermanos Ameijeiras

Especialista de Primer Grado en Genética Clínica. Profesora Auxiliar.

Raúl Orlando Calderín Bouza, Hospital Hermanos Ameijeiras

Especialista de segundo grado

Profesor e Investigador Auxiliar en Medicina Interna.

Miguel Ángel Yanes Quesada, Hospital Hermanos Ameijeira

Especialista de Segundo Grado

Profesor Auxiliar en Medicina Interna.

References

Lonser R, Glenn G, Walther M, Chew E, Libutti S, Linehan W, et al. Von Hippel-Lindau disease. Lancet. 2003;361(9374):2059-67. DOI: https://doi.org/10.1016/S0140-6736(03)13643-4

Wolters W, Dreijerink K, Giles R, van der Horst-Schrivers A, van Nesselrooij B, Zandee W, et al. Multidisciplinary integrated care pathway for Von Hippel-Lindau disease. Cancer. 2022;128(15):2871-9. DOI: https://doi.org/10.1002/cncr.34265

Villar K. Descripción de la enfermedad de Von Hippel-Lindau en tres familias españolas. An Med Interna (Madrid). 2002 [acceso 10/11/2024];19:352-6. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-71992002000700005&lng=es

Schunemann V, Huntoon K, Lonser R. Personalized Medicine for Nervous System Manifestations of Von Hippel-Lindau Disease. Front Surg. 2016;3:39. DOI: https://doi.org/10.3389/fsurg.2016.00039

Huntoon K, Wu T, Elder J, Butman J, Chew E, Linehan W, et al. Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in Von Hippel-Lindau disease. J Neurosurg. 2016;124(4):971-6. DOI: https://doi.org/10.3171/2015.4.JNS1533

Kanno H, Kuratsu J, Nishikawa R, Mishima K, Natsume A, Wakabayashi T, et al. Clinical features of patients bearing central nervous system hemangioblastoma in Von Hippel-Lindau disease. Acta Neurochir (Wien). 2013;155(1):1-7. DOI: https://doi.org/10.1007/s00701-012-1514-y

Lonser R, Butman J, Huntoon K, Asthagiri A, Wu T, Bakhtian K, et al. Prospective natural history study of central nervous system hemangioblastomas in Von Hippel-Lindau disease. J Neurosurg. 2014;120(5):1055-62. DOI: https://doi.org/10.3171/2014.1. JNS131431

Klingler J, Gläsker S, Bausch B, Urbach H, Krauss T, Jilg C, et al. Hemangioblastoma and Von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment. Childs Nerv Syst. 2020;36(10):2537-52. DOI: https://doig.org/10.1007/s00381-020-04712-5

Shepherd S, Drake W, Turajlic S. The road to systemic therapy in Von Hippel-Lindau (VHL) disease: ¿Are we there yet? Eur J Cancer. 2023;182:15-2. DOI: https://doi.org/10.1016/j.ejca.2022.12.011

Published

2024-11-22

How to Cite

1.
Concepción Quero F, Noa Hechavarría I, Calderín Bouza RO, Yanes Quesada M Ángel. Von Hippel Lindau Disease: Two Sisters and one Disease. Acta Médica [Internet]. 2024 Nov. 22 [cited 2025 Apr. 10];25. Available from: https://revactamedica.sld.cu/index.php/act/article/view/498

Issue

Section

Presentación de caso